课题基金 / 基金详情

REPTOR as a mechanism for aging control by dietary restriction and rapamycin

REPTOR as a mechanism for aging control by dietary restriction and rapamycin
REPTOR作为通过饮食限制和雷帕霉素控制衰老的机制
批准号:
9299810
负责人:
MARC TATAR
金额:
$20.31万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-03-01 至 2019-02-28

项目摘要

项目成果

MARC TATAR的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract Dietary restriction (DR) extends life span and retards aging-associated pathology. Rapamycin likewise extends survival and reduces aging-related disease in mice, and extends lifespan in Drosophila. These manipulations share a common effector through the kinase Target of Rapamycin complex 1 (TORC1). TORC1 impacts translation and autophagy, processes with potential to control aging. Intensive work currently focuses on how these TORC1-affiliated systems are required for rapamycin and DR to slow aging. Aside from its control of protein production, TORC1 impacts gene expression. Rapamycin induces hundreds of genes in mammals and Drosophila. How TORC1 directly affects transcription is largely unknown, but recent work in Drosophila reveals a novel mechanism: dTORC1 phosphorylates the transcriptional cofactor REPTOR (“Repressed by TOR”). REPTOR interacts with REPTOR-BP to control ~300 rapamycin/dTORC1-mediated genes. Furthermore, REPTOR and REPTOR-BP are regulated by dietary amino acids in Drosophila, and we find that their mammalian homologs (CREBRF and CREBL2) mediate glucose metabolism in mice. As an Exploratory/Developmental Research Grant (R21) this proposal intends to break new ground in understanding how DR and rapamycin function with TORC1 to control aging via REPTOR. Our preliminary results are positive: REPTOR is essential for DR to slow aging and in particular, DR requires REPTOR in neurons or gut cells to extend lifespan. REPTOR -- and perhaps by extension DR, TORC1 and rapamycin -- appears to slow aging through non-autonomous TORC1 mediated mechanisms. Here we aim to determine whether activated REPTOR is sufficient to slow aging in Drosophila, whether rapamycin requires REPTOR and REPTOR-BP to slow aging, and which cells require REPTOR and REPTOR-BP for DR to slow aging. These are early steps in a research program needed to set-up future work on the cellular mechanisms through which REPTOR controls aging.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genome wide association analysis with Drosophila to discover how metformin effects longevity
  • 批准号:
    10085915
  • 项目类别:
  • 资助金额:
    $38.1万
  • 财政年份:
    2020
  • 负责人:
    MARC TATAR
  • 依托单位:
Innate immune dysregulation in Alzheimer's disease modeled in Drosophila
  • 批准号:
    10259828
  • 项目类别:
  • 资助金额:
    $18.69万
  • 财政年份:
    2020
  • 负责人:
    MARC TATAR
  • 依托单位:
Genome wide association analysis with Drosophila to discover how metformin effects longevity
  • 批准号:
    10645126
  • 项目类别:
  • 资助金额:
    $39.88万
  • 财政年份:
    2020
  • 负责人:
    MARC TATAR
  • 依托单位:
Genome wide association analysis with Drosophila to discover how metformin effects longevity
  • 批准号:
    10424563
  • 项目类别:
  • 资助金额:
    $39.86万
  • 财政年份:
    2020
  • 负责人:
    MARC TATAR
  • 依托单位:
海外基金